MHC associations of ankylosing spondylitis in East Asians are complex and involve non-HLA-B27 HLA contributions

The association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease. Nonetheless, there is strong evidence indicating that other HLA-B alleles are involved in the disease. European ethnicity studies have demonstrated risk associations with...

Full description

Saved in:
Bibliographic Details
Published inArthritis research & therapy Vol. 22; no. 1; pp. 74 - 8
Main Authors Wang, Geng, Kim, Tae-Hwan, Li, Zhixiu, Cortes, Adrian, Kim, Kwangwoo, Bang, So-Young, Leo, Paul, Brown, Matthew A., Xu, Huji
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 09.04.2020
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease. Nonetheless, there is strong evidence indicating that other HLA-B alleles are involved in the disease. European ethnicity studies have demonstrated risk associations with HLA-B*40 and multiple other HLA-B, HLA-A, and HLA class II alleles, and demonstrated that in that ethnic group, the amino acid sequence at position 97 in HLA-B is the key determinant of HLA associations with AS. A recent study in Korean AS cases and controls additionally identified association at HLA-C*15:02. In the current study, we examined the MHC associations of AS in an expanded East Asian cohort. A total of 1637 Chinese, Taiwanese, and Korean AS cases meeting the modified New York Criteria for AS, and 1589 ethnically matched controls, were genotyped with the Illumina Immunochip, including a dense coverage of the MHC region. HLA genotypes and amino acid composition were imputed using the SNP2HLA programme using the Han-MHC reference panel based on the data of Han Chinese subjects (n = 9689), and association tested using logistic regression controlling for population stratification effects. A strong association was seen with HLA-B*27 (odds ratio (OR) = 205.3, P = 5.76 × 10 ). Controlling for this association, the strongest risk association is seen with HLA-C*15 at genome-wide significant level (OR = 7.62, P = 9.30 × 10 ), and confirmed association is also seen with HLA-B*40 at suggestive level (OR = 1.65, P = 2.54 × 10 ). At amino acid level, the strongest association seen in uncontrolled analysis was with histidine at position 114 in HLA-B (P = 7.24 × 10 ), but conditional analyses suggest that the primary amino acid associations are with lysine at position 70 and asparagine at position 97. Restriction of the ERAP1 association with HLA-B27-positive AS, previously reported in European subjects, was confirmed in East Asians. This study confirms in East Asians that the HLA associations of AS are multiple, including previously reported associations at HLA-B*27, HLA-B*40, and HLA-C*15, as well as novel association with HLA-DQB1*04. The HLA-B associations are driven by the amino acids at positions 70 and 97, in the B pocket of HLA-B.
AbstractList The association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease. Nonetheless, there is strong evidence indicating that other HLA-B alleles are involved in the disease. European ethnicity studies have demonstrated risk associations with HLA-B*40 and multiple other HLA-B, HLA-A, and HLA class II alleles, and demonstrated that in that ethnic group, the amino acid sequence at position 97 in HLA-B is the key determinant of HLA associations with AS. A recent study in Korean AS cases and controls additionally identified association at HLA-C*15:02. In the current study, we examined the MHC associations of AS in an expanded East Asian cohort.BACKGROUNDThe association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease. Nonetheless, there is strong evidence indicating that other HLA-B alleles are involved in the disease. European ethnicity studies have demonstrated risk associations with HLA-B*40 and multiple other HLA-B, HLA-A, and HLA class II alleles, and demonstrated that in that ethnic group, the amino acid sequence at position 97 in HLA-B is the key determinant of HLA associations with AS. A recent study in Korean AS cases and controls additionally identified association at HLA-C*15:02. In the current study, we examined the MHC associations of AS in an expanded East Asian cohort.A total of 1637 Chinese, Taiwanese, and Korean AS cases meeting the modified New York Criteria for AS, and 1589 ethnically matched controls, were genotyped with the Illumina Immunochip, including a dense coverage of the MHC region. HLA genotypes and amino acid composition were imputed using the SNP2HLA programme using the Han-MHC reference panel based on the data of Han Chinese subjects (n = 9689), and association tested using logistic regression controlling for population stratification effects.METHODSA total of 1637 Chinese, Taiwanese, and Korean AS cases meeting the modified New York Criteria for AS, and 1589 ethnically matched controls, were genotyped with the Illumina Immunochip, including a dense coverage of the MHC region. HLA genotypes and amino acid composition were imputed using the SNP2HLA programme using the Han-MHC reference panel based on the data of Han Chinese subjects (n = 9689), and association tested using logistic regression controlling for population stratification effects.A strong association was seen with HLA-B*27 (odds ratio (OR) = 205.3, P = 5.76 × 10-244). Controlling for this association, the strongest risk association is seen with HLA-C*15 at genome-wide significant level (OR = 7.62, P = 9.30 × 10-19), and confirmed association is also seen with HLA-B*40 at suggestive level (OR = 1.65, P = 2.54 × 10-4). At amino acid level, the strongest association seen in uncontrolled analysis was with histidine at position 114 in HLA-B (P = 7.24 × 10-241), but conditional analyses suggest that the primary amino acid associations are with lysine at position 70 and asparagine at position 97. Restriction of the ERAP1 association with HLA-B27-positive AS, previously reported in European subjects, was confirmed in East Asians.RESULTSA strong association was seen with HLA-B*27 (odds ratio (OR) = 205.3, P = 5.76 × 10-244). Controlling for this association, the strongest risk association is seen with HLA-C*15 at genome-wide significant level (OR = 7.62, P = 9.30 × 10-19), and confirmed association is also seen with HLA-B*40 at suggestive level (OR = 1.65, P = 2.54 × 10-4). At amino acid level, the strongest association seen in uncontrolled analysis was with histidine at position 114 in HLA-B (P = 7.24 × 10-241), but conditional analyses suggest that the primary amino acid associations are with lysine at position 70 and asparagine at position 97. Restriction of the ERAP1 association with HLA-B27-positive AS, previously reported in European subjects, was confirmed in East Asians.This study confirms in East Asians that the HLA associations of AS are multiple, including previously reported associations at HLA-B*27, HLA-B*40, and HLA-C*15, as well as novel association with HLA-DQB1*04. The HLA-B associations are driven by the amino acids at positions 70 and 97, in the B pocket of HLA-B.CONCLUSIONSThis study confirms in East Asians that the HLA associations of AS are multiple, including previously reported associations at HLA-B*27, HLA-B*40, and HLA-C*15, as well as novel association with HLA-DQB1*04. The HLA-B associations are driven by the amino acids at positions 70 and 97, in the B pocket of HLA-B.
The association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease. Nonetheless, there is strong evidence indicating that other HLA-B alleles are involved in the disease. European ethnicity studies have demonstrated risk associations with HLA-B*40 and multiple other HLA-B, HLA-A, and HLA class II alleles, and demonstrated that in that ethnic group, the amino acid sequence at position 97 in HLA-B is the key determinant of HLA associations with AS. A recent study in Korean AS cases and controls additionally identified association at HLA-C*15:02. In the current study, we examined the MHC associations of AS in an expanded East Asian cohort. A total of 1637 Chinese, Taiwanese, and Korean AS cases meeting the modified New York Criteria for AS, and 1589 ethnically matched controls, were genotyped with the Illumina Immunochip, including a dense coverage of the MHC region. HLA genotypes and amino acid composition were imputed using the SNP2HLA programme using the Han-MHC reference panel based on the data of Han Chinese subjects (n = 9689), and association tested using logistic regression controlling for population stratification effects. A strong association was seen with HLA-B*27 (odds ratio (OR) = 205.3, P = 5.76 × 10 ). Controlling for this association, the strongest risk association is seen with HLA-C*15 at genome-wide significant level (OR = 7.62, P = 9.30 × 10 ), and confirmed association is also seen with HLA-B*40 at suggestive level (OR = 1.65, P = 2.54 × 10 ). At amino acid level, the strongest association seen in uncontrolled analysis was with histidine at position 114 in HLA-B (P = 7.24 × 10 ), but conditional analyses suggest that the primary amino acid associations are with lysine at position 70 and asparagine at position 97. Restriction of the ERAP1 association with HLA-B27-positive AS, previously reported in European subjects, was confirmed in East Asians. This study confirms in East Asians that the HLA associations of AS are multiple, including previously reported associations at HLA-B*27, HLA-B*40, and HLA-C*15, as well as novel association with HLA-DQB1*04. The HLA-B associations are driven by the amino acids at positions 70 and 97, in the B pocket of HLA-B.
Abstract Background The association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease. Nonetheless, there is strong evidence indicating that other HLA-B alleles are involved in the disease. European ethnicity studies have demonstrated risk associations with HLA-B*40 and multiple other HLA-B, HLA-A, and HLA class II alleles, and demonstrated that in that ethnic group, the amino acid sequence at position 97 in HLA-B is the key determinant of HLA associations with AS. A recent study in Korean AS cases and controls additionally identified association at HLA-C*15:02. In the current study, we examined the MHC associations of AS in an expanded East Asian cohort. Methods A total of 1637 Chinese, Taiwanese, and Korean AS cases meeting the modified New York Criteria for AS, and 1589 ethnically matched controls, were genotyped with the Illumina Immunochip, including a dense coverage of the MHC region. HLA genotypes and amino acid composition were imputed using the SNP2HLA programme using the Han-MHC reference panel based on the data of Han Chinese subjects (n = 9689), and association tested using logistic regression controlling for population stratification effects. Results A strong association was seen with HLA-B*27 (odds ratio (OR) = 205.3, P = 5.76 × 10−244). Controlling for this association, the strongest risk association is seen with HLA-C*15 at genome-wide significant level (OR = 7.62, P = 9.30 × 10−19), and confirmed association is also seen with HLA-B*40 at suggestive level (OR = 1.65, P = 2.54 × 10−4). At amino acid level, the strongest association seen in uncontrolled analysis was with histidine at position 114 in HLA-B (P = 7.24 × 10−241), but conditional analyses suggest that the primary amino acid associations are with lysine at position 70 and asparagine at position 97. Restriction of the ERAP1 association with HLA-B27-positive AS, previously reported in European subjects, was confirmed in East Asians. Conclusions This study confirms in East Asians that the HLA associations of AS are multiple, including previously reported associations at HLA-B*27, HLA-B*40, and HLA-C*15, as well as novel association with HLA-DQB1*04. The HLA-B associations are driven by the amino acids at positions 70 and 97, in the B pocket of HLA-B.
Background The association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease. Nonetheless, there is strong evidence indicating that other HLA-B alleles are involved in the disease. European ethnicity studies have demonstrated risk associations with HLA-B*40 and multiple other HLA-B, HLA-A, and HLA class II alleles, and demonstrated that in that ethnic group, the amino acid sequence at position 97 in HLA-B is the key determinant of HLA associations with AS. A recent study in Korean AS cases and controls additionally identified association at HLA-C*15:02. In the current study, we examined the MHC associations of AS in an expanded East Asian cohort. Methods A total of 1637 Chinese, Taiwanese, and Korean AS cases meeting the modified New York Criteria for AS, and 1589 ethnically matched controls, were genotyped with the Illumina Immunochip, including a dense coverage of the MHC region. HLA genotypes and amino acid composition were imputed using the SNP2HLA programme using the Han-MHC reference panel based on the data of Han Chinese subjects (n = 9689), and association tested using logistic regression controlling for population stratification effects. Results A strong association was seen with HLA-B*27 (odds ratio (OR) = 205.3, P = 5.76 × 10−244). Controlling for this association, the strongest risk association is seen with HLA-C*15 at genome-wide significant level (OR = 7.62, P = 9.30 × 10−19), and confirmed association is also seen with HLA-B*40 at suggestive level (OR = 1.65, P = 2.54 × 10−4). At amino acid level, the strongest association seen in uncontrolled analysis was with histidine at position 114 in HLA-B (P = 7.24 × 10−241), but conditional analyses suggest that the primary amino acid associations are with lysine at position 70 and asparagine at position 97. Restriction of the ERAP1 association with HLA-B27-positive AS, previously reported in European subjects, was confirmed in East Asians. Conclusions This study confirms in East Asians that the HLA associations of AS are multiple, including previously reported associations at HLA-B*27, HLA-B*40, and HLA-C*15, as well as novel association with HLA-DQB1*04. The HLA-B associations are driven by the amino acids at positions 70 and 97, in the B pocket of HLA-B.
Background The association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease. Nonetheless, there is strong evidence indicating that other HLA-B alleles are involved in the disease. European ethnicity studies have demonstrated risk associations with HLA-B*40 and multiple other HLA-B, HLA-A, and HLA class II alleles, and demonstrated that in that ethnic group, the amino acid sequence at position 97 in HLA-B is the key determinant of HLA associations with AS. A recent study in Korean AS cases and controls additionally identified association at HLA-C*15:02. In the current study, we examined the MHC associations of AS in an expanded East Asian cohort. Methods A total of 1637 Chinese, Taiwanese, and Korean AS cases meeting the modified New York Criteria for AS, and 1589 ethnically matched controls, were genotyped with the Illumina Immunochip, including a dense coverage of the MHC region. HLA genotypes and amino acid composition were imputed using the SNP2HLA programme using the Han-MHC reference panel based on the data of Han Chinese subjects (n = 9689), and association tested using logistic regression controlling for population stratification effects. Results A strong association was seen with HLA-B*27 (odds ratio (OR) = 205.3, P = 5.76 x 10.sup.-244). Controlling for this association, the strongest risk association is seen with HLA-C*15 at genome-wide significant level (OR = 7.62, P = 9.30 x 10.sup.-19), and confirmed association is also seen with HLA-B*40 at suggestive level (OR = 1.65, P = 2.54 x 10.sup.-4). At amino acid level, the strongest association seen in uncontrolled analysis was with histidine at position 114 in HLA-B (P = 7.24 x 10.sup.-241), but conditional analyses suggest that the primary amino acid associations are with lysine at position 70 and asparagine at position 97. Restriction of the ERAP1 association with HLA-B27-positive AS, previously reported in European subjects, was confirmed in East Asians. Conclusions This study confirms in East Asians that the HLA associations of AS are multiple, including previously reported associations at HLA-B*27, HLA-B*40, and HLA-C*15, as well as novel association with HLA-DQB1*04. The HLA-B associations are driven by the amino acids at positions 70 and 97, in the B pocket of HLA-B. Keywords: Ankylosing spondylitis, HLA, Association
The association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease. Nonetheless, there is strong evidence indicating that other HLA-B alleles are involved in the disease. European ethnicity studies have demonstrated risk associations with HLA-B*40 and multiple other HLA-B, HLA-A, and HLA class II alleles, and demonstrated that in that ethnic group, the amino acid sequence at position 97 in HLA-B is the key determinant of HLA associations with AS. A recent study in Korean AS cases and controls additionally identified association at HLA-C*15:02. In the current study, we examined the MHC associations of AS in an expanded East Asian cohort. A total of 1637 Chinese, Taiwanese, and Korean AS cases meeting the modified New York Criteria for AS, and 1589 ethnically matched controls, were genotyped with the Illumina Immunochip, including a dense coverage of the MHC region. HLA genotypes and amino acid composition were imputed using the SNP2HLA programme using the Han-MHC reference panel based on the data of Han Chinese subjects (n = 9689), and association tested using logistic regression controlling for population stratification effects. A strong association was seen with HLA-B*27 (odds ratio (OR) = 205.3, P = 5.76 x 10.sup.-244). Controlling for this association, the strongest risk association is seen with HLA-C*15 at genome-wide significant level (OR = 7.62, P = 9.30 x 10.sup.-19), and confirmed association is also seen with HLA-B*40 at suggestive level (OR = 1.65, P = 2.54 x 10.sup.-4). At amino acid level, the strongest association seen in uncontrolled analysis was with histidine at position 114 in HLA-B (P = 7.24 x 10.sup.-241), but conditional analyses suggest that the primary amino acid associations are with lysine at position 70 and asparagine at position 97. Restriction of the ERAP1 association with HLA-B27-positive AS, previously reported in European subjects, was confirmed in East Asians. This study confirms in East Asians that the HLA associations of AS are multiple, including previously reported associations at HLA-B*27, HLA-B*40, and HLA-C*15, as well as novel association with HLA-DQB1*04. The HLA-B associations are driven by the amino acids at positions 70 and 97, in the B pocket of HLA-B.
ArticleNumber 74
Audience Academic
Author Bang, So-Young
Li, Zhixiu
Kim, Kwangwoo
Brown, Matthew A.
Kim, Tae-Hwan
Xu, Huji
Cortes, Adrian
Leo, Paul
Wang, Geng
Author_xml – sequence: 1
  givenname: Geng
  surname: Wang
  fullname: Wang, Geng
– sequence: 2
  givenname: Tae-Hwan
  surname: Kim
  fullname: Kim, Tae-Hwan
– sequence: 3
  givenname: Zhixiu
  surname: Li
  fullname: Li, Zhixiu
– sequence: 4
  givenname: Adrian
  surname: Cortes
  fullname: Cortes, Adrian
– sequence: 5
  givenname: Kwangwoo
  surname: Kim
  fullname: Kim, Kwangwoo
– sequence: 6
  givenname: So-Young
  surname: Bang
  fullname: Bang, So-Young
– sequence: 7
  givenname: Paul
  surname: Leo
  fullname: Leo, Paul
– sequence: 8
  givenname: Matthew A.
  surname: Brown
  fullname: Brown, Matthew A.
– sequence: 9
  givenname: Huji
  surname: Xu
  fullname: Xu, Huji
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32272966$$D View this record in MEDLINE/PubMed
BookMark eNp9ks2O0zAURiM0iPmBF2CBIrFhk8G-Tmxng9SpBjpSERtYW7ZjF5fULnFa0bfntp2B6QihKLJln3uSa3-XxVlM0RXFa0quKZX8faaMiKYiQPCltayaZ8UFrYWsOONw9mh-XlzmvCQEoIX6RXHOAAS0nF8U6fNsWuqckw16DCnmMvlSxx-7PuUQF2Vep9jt-jCGXIZY3uo8lpMcNIJ6cKVNq3XvfmFFh9vb1G9diX9ZzeaT6gZEiSMycRyC2Rz0L4vnXvfZvbofr4pvH2-_TmfV_Munu-lkXtmGs7FqvLC2lcw7aTxvCaOESWM6LltBWMMk5a4zDRWMe8KBO2OFpcQzINpQK9hVcXf0dkkv1XoIKz3sVNJBHRbSsFB6GIPtnWKG0RYM07SBmoGVxONhGrC8pV3nCLo-HF3rjVm5zjrsR_cn0tOdGL6rRdoqQWveygYF7-4FQ_q5cXlUq5Ct63sdXdpkBUxKCQC1RPTtE3SZNkPEo0KqpSDw6uq_1EJjAyH6hN-1e6macGQYpaJF6vofFD6dWwW8FecDrp8UvHnc6J8OH-KCgDwCdkg5D84rG8ZDbtAcekWJ2idTHZOpMJnqkEy1PwN4Uvpg_0_Rb8T84t8
CitedBy_id crossref_primary_10_3389_fimmu_2022_838891
crossref_primary_10_4103_NJPT_NJPT_2_24
crossref_primary_10_1007_s00125_021_05476_6
crossref_primary_10_3390_ijms25116081
crossref_primary_10_1111_1756_185X_14846
crossref_primary_10_3389_fgene_2021_671682
crossref_primary_10_1016_j_berh_2024_101982
crossref_primary_10_4103_aam_aam_180_23
crossref_primary_10_1097_BOR_0000000000000946
crossref_primary_10_1007_s11926_022_01079_1
crossref_primary_10_1136_rmdopen_2024_004589
crossref_primary_10_1111_1756_185X_14055
crossref_primary_10_4078_jrd_2023_0041
crossref_primary_10_1136_ard_2022_222852
crossref_primary_10_3389_fimmu_2023_1104351
crossref_primary_10_1016_j_mehy_2022_111000
crossref_primary_10_2478_rrlm_2023_0012
Cites_doi 10.1038/ng.1047
10.1038/ng.873
10.1073/pnas.1618856114
10.1002/anr.1780320912
10.2174/1874312920130628001
10.1086/519795
10.1186/ar3204
10.1038/ng.3576
10.1038/ng.3656
10.1038/ng.1005
10.1186/ar3855
10.1038/ncomms8146
10.3899/jrheum.151096
10.1093/rheumatology/keh193
10.1371/journal.pone.0007888
10.1002/art.1780270401
10.1038/ng.2667
10.1186/s13075-015-0855-3
10.1136/ard.55.4.268
10.1007/s00251-015-0849-y
ContentType Journal Article
Copyright COPYRIGHT 2020 BioMed Central Ltd.
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2020
Copyright_xml – notice: COPYRIGHT 2020 BioMed Central Ltd.
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2020
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1186/s13075-020-02148-5
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Publicly Available Content Database


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1478-6362
EndPage 8
ExternalDocumentID oai_doaj_org_article_3b3192b3a152432c80f148b2c691dde0
PMC7146985
A627331179
32272966
10_1186_s13075_020_02148_5
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations China
Republic of Korea
Taiwan
South Korea
Asia
GeographicLocations_xml – name: China
– name: Republic of Korea
– name: Taiwan
– name: South Korea
– name: Asia
GrantInformation_xml – fundername: National Health and Medical Research Council
  grantid: 1024879
– fundername: ;
  grantid: 1024879
GroupedDBID ---
.GJ
0R~
23N
2WC
4.4
5GY
5VS
6J9
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABUWG
ACGFS
ACJQM
ADBBV
ADUKV
AEGXH
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIAM
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
E3Z
EBD
EBLON
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
HZ~
INH
INR
ITC
KQ8
M1P
O5R
O5S
O9-
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
U2A
UKHRP
WOQ
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c563t-5f7cc983fe8bf69031038bbd68970353816edb51736f0626ebc7c10f320ab1c73
IEDL.DBID DOA
ISSN 1478-6362
1478-6354
IngestDate Wed Aug 27 01:31:24 EDT 2025
Thu Aug 21 13:47:31 EDT 2025
Mon Jul 21 11:57:59 EDT 2025
Wed Aug 20 03:02:21 EDT 2025
Tue Jun 17 21:25:50 EDT 2025
Tue Jun 10 20:39:11 EDT 2025
Thu Apr 03 07:04:34 EDT 2025
Tue Jul 01 04:00:55 EDT 2025
Thu Apr 24 22:49:46 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords HLA
Ankylosing spondylitis
Association
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c563t-5f7cc983fe8bf69031038bbd68970353816edb51736f0626ebc7c10f320ab1c73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doaj.org/article/3b3192b3a152432c80f148b2c691dde0
PMID 32272966
PQID 2391273224
PQPubID 42876
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_3b3192b3a152432c80f148b2c691dde0
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7146985
proquest_miscellaneous_2388822248
proquest_journals_2391273224
gale_infotracmisc_A627331179
gale_infotracacademiconefile_A627331179
pubmed_primary_32272966
crossref_citationtrail_10_1186_s13075_020_02148_5
crossref_primary_10_1186_s13075_020_02148_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-04-09
PublicationDateYYYYMMDD 2020-04-09
PublicationDate_xml – month: 04
  year: 2020
  text: 2020-04-09
  day: 09
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Arthritis research & therapy
PublicationTitleAlternate Arthritis Res Ther
PublicationYear 2020
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References S Purcell (2148_CR10) 2007; 81
HW van Deutekom (2148_CR19) 2015; 67
Z Lin (2148_CR11) 2011; 44
D Lopez Herraez (2148_CR7) 2009; 4
AR Roberts (2148_CR13) 2017; 114
A Cortes (2148_CR1) 2015; 6
JC Wei (2148_CR17) 2004; 43
WP Robinson (2148_CR14) 1989; 32
XQ Yu (2148_CR18) 2011; 44
L Yi (2148_CR3) 2013; 7
A Cortes (2148_CR6) 2011; 13
MA Brown (2148_CR16) 1996; 55
S van der Linden (2148_CR5) 1984; 27
A Cortes (2148_CR4) 2013; 45
DM Evans (2148_CR12) 2011; 43
S Das (2148_CR8) 2016; 48
K Kim (2148_CR2) 2015; 17
F Zhou (2148_CR9) 2016; 48
CM Wang (2148_CR20) 2012; 14
R Diaz-Pena (2148_CR15) 2016; 43
References_xml – volume: 44
  start-page: 178
  issue: 2
  year: 2011
  ident: 2148_CR18
  publication-title: Nat Genet
  doi: 10.1038/ng.1047
– volume: 43
  start-page: 761
  issue: 8
  year: 2011
  ident: 2148_CR12
  publication-title: Nat Genet
  doi: 10.1038/ng.873
– volume: 114
  start-page: 558
  issue: 3
  year: 2017
  ident: 2148_CR13
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1618856114
– volume: 32
  start-page: 1135
  issue: 9
  year: 1989
  ident: 2148_CR14
  publication-title: Arthritis Rheum
  doi: 10.1002/anr.1780320912
– volume: 7
  start-page: 51
  year: 2013
  ident: 2148_CR3
  publication-title: Open Rheumatol J
  doi: 10.2174/1874312920130628001
– volume: 81
  start-page: 559
  issue: 3
  year: 2007
  ident: 2148_CR10
  publication-title: Am J Hum Genet
  doi: 10.1086/519795
– volume: 13
  start-page: 101
  issue: 1
  year: 2011
  ident: 2148_CR6
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar3204
– volume: 48
  start-page: 740
  issue: 7
  year: 2016
  ident: 2148_CR9
  publication-title: Nat Genet
  doi: 10.1038/ng.3576
– volume: 48
  start-page: 1284
  issue: 10
  year: 2016
  ident: 2148_CR8
  publication-title: Nat Genet
  doi: 10.1038/ng.3656
– volume: 44
  start-page: 73
  issue: 1
  year: 2011
  ident: 2148_CR11
  publication-title: Nat Genet
  doi: 10.1038/ng.1005
– volume: 14
  start-page: R125
  issue: 3
  year: 2012
  ident: 2148_CR20
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar3855
– volume: 6
  start-page: 7146
  year: 2015
  ident: 2148_CR1
  publication-title: Nat Commun
  doi: 10.1038/ncomms8146
– volume: 43
  start-page: 1255
  issue: 6
  year: 2016
  ident: 2148_CR15
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.151096
– volume: 43
  start-page: 839
  issue: 7
  year: 2004
  ident: 2148_CR17
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/keh193
– volume: 4
  issue: 11
  year: 2009
  ident: 2148_CR7
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0007888
– volume: 27
  start-page: 361
  issue: 4
  year: 1984
  ident: 2148_CR5
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780270401
– volume: 45
  start-page: 730
  issue: 7
  year: 2013
  ident: 2148_CR4
  publication-title: Nat Genet
  doi: 10.1038/ng.2667
– volume: 17
  start-page: 342
  year: 2015
  ident: 2148_CR2
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-015-0855-3
– volume: 55
  start-page: 268
  issue: 4
  year: 1996
  ident: 2148_CR16
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.55.4.268
– volume: 67
  start-page: 425
  issue: 8
  year: 2015
  ident: 2148_CR19
  publication-title: Immunogenetics
  doi: 10.1007/s00251-015-0849-y
SSID ssj0022924
Score 2.3958032
Snippet The association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease. Nonetheless, there is strong...
Background The association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease. Nonetheless, there...
Abstract Background The association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease....
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 74
SubjectTerms Alleles
Amino acids
Analysis
Ankylosing spondylitis
Arthritis
Asian Continental Ancestry Group - genetics
Asian people
Asians
Association
China
Gene Frequency
Genetic Predisposition to Disease - ethnology
Genetic Predisposition to Disease - genetics
Genomics
Genotype
HLA
HLA antigens
HLA Antigens - genetics
HLA-B27 Antigen - genetics
HLA-C Antigens - genetics
Humans
Medical research
Pathology
Polymorphism, Single Nucleotide
Republic of Korea
Spondylitis, Ankylosing - ethnology
Spondylitis, Ankylosing - genetics
Taiwan
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96gvgifls9JYLgg4Rr2jRJn2TvuGMR1ycP9i3ko9HjpD23e6L_vTPZ7O4V4Z4KmwxtdmZ-M5NMZgh5rxwPZWkDc1FUEKDolrXBaaY9IKEFnodUXX_xVc7Pxedls8wbbmNOq9xiYgLqMHjcIz-q6paDqQWL8-nqF8OuUXi6mlto3CX3sHQZpnSp5T7gqtpNU1sBkRIYVrG9NKPl0QjYrfBucsmwaphmzcQwpfr9_6P0DTM1TaG8YZPOHpGH2Zmksw33H5M7Xf-E3F_k4_KnZFjMT6jdM2CkQ6S2v4QgHbcIKKbHhr-YADfSi56e2nFNZ3ircqR21dGUbt79AYoAw4BjvzvaDz2bf5mx40pReNKU6p57Zo3PyPnZ6beTOcsdFphvZL1mTVTet7qOnXYR4mRsOqadC1K3gAQNHip2wTVc1TKWEPp0zivPy1hXpXXcq_o5OYD3di8J5UpxH0JseQxCN9EJ68E7kE5pK9paFIRv_17jc_lx7ILx06QwREuzYYkBlpjEEtMU5OOO5mpTfOPW2cfItd1MLJydfhhW303WQ1M7kL_K1Rb8FlFXXpcRiF3lZcsB6cuCfECeG1Rv-Dxv8y0FWCQWyjIzWWGXS4CxghxOZoJa-unwVmpMhoXR7IW4IO92w0iJqW59N1zjHK3RaxO6IC82QrZbElBCMCRlQdRE_CZrno70Fz9S0XDFsVdo8-r2z3pNHlRJJwQr20NysF5dd2_A61q7t0m1_gH75CZ0
  priority: 102
  providerName: ProQuest
Title MHC associations of ankylosing spondylitis in East Asians are complex and involve non-HLA-B27 HLA contributions
URI https://www.ncbi.nlm.nih.gov/pubmed/32272966
https://www.proquest.com/docview/2391273224
https://www.proquest.com/docview/2388822248
https://pubmed.ncbi.nlm.nih.gov/PMC7146985
https://doaj.org/article/3b3192b3a152432c80f148b2c691dde0
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA96gvgifls9lwiCDxKuSdskfdw99ljEPURc2LeQjwaPk65c947zv3cm7a5bBH3xZQubGdpkPjK_djJDyDvleMhzG5iLpQCAomtWB6eZ9uAJLcg8pOr6y3O5WJUf19X6oNUX5oT15YH7hTspHDAIV1jYaMpCeJ1HiOCd8LLmYJoJrcOetwNTA9QSACt2R2S0POnAUys8iZwzrBGmWTXahlK1_j998sGmNE6YPNiBzh6Rh0PoSKf9Iz8md5r2Cbm_HD6OPyWb5eKU2t_L3dFNpLa9BEiOLwQoJsOGn5ju1tGLls5tt6VTPEPZUXvV0JRc3twCR4Bh8Fo3DW03LVt8mrKZUBSuNCW2Dx2yumdkdTb_erpgQz8F5itZbFkVlfe1LmKjXQRUjC3GtHNB6hrsvsJPiE1wFVeFjDkAncZ55XkeC5Fbx70qnpMjuG_zklCuFPchxJrHUOoqutJ6iAWkU9qWdVFmhO-W1_ih2Dj2vPhuEujQ0vQiMSASk0Riqox82PP86Ett_JV6hlLbU2KZ7PQHKI8ZlMf8S3ky8h5lbtCY4fG8Hc4kwCSxLJaZSoE9LcFpZeR4RAlG6MfDO60xgxPojChqDgQQJGXk7X4YOTGxrW0210ijNcZopc7Ii17J9lMCToA-UmZEjdRvNOfxSHvxLZUIVxw7g1av_scivSYPRLKckuX1MTnaXl03byAS27oJuavWakLuzebnn79MkgnC70pMfwFnjC-1
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJ8FeEN8EBhgJxAOyljhO7Dwg1I5OHWsrhDZpbya2EzYxJaPpgP5T_I3c5aNbhLS3PVWKfWmcO99HfHc_Qt5IEzjfTx0zueAQoKiEJc4opixowhR47uru-rN5PDkSn4-j4w3yt6uFwbTKTifWitqVFr-R7_AwCcDUgsX5eP6TIWoUnq52EBqNWBxkq98QslUf9j8Bf99yvjc-3J2wFlWA2SgOlyzKpbWJCvNMmRxiQwTaUsa4WCUg_REepGXORIEM49wHdz8zVtrAz0PupyawMoT73iKbIoRQZkA2R-P5l6_rEI8nDYyugNgMTLnoynRUvFOBtZBYDe0z7FOmWNQzhTViwP924Yph7CdtXrGCe_fI3dZ9pcNG3u6Tjax4QG7P2gP6h6ScTXZpesnyipY5TYsfq7MSP0pQTMh1K0y5q-hpQcdptaRDrOOsaLrIaJ3gnv0BCgfDoDl_ZbQoCzaZDtmISwq_tE6ub1G6qkfk6Ebe_mMygP_NnhIaSBlY5_IkyJ1QUW5EasEfiY1UqUhC4ZGge73atg3PEXfjTNeBj4p1wxINLNE1S3TkkfdrmvOm3ce1s0fItfVMbNVdXygX33W783VoQOK5CVPwlETIrfJzIDbcxkkAtsX3yDvkuUaFAo9n07YuAhaJrbn0MOaIqwmK0yPbvZmgCGx_uJMa3SqiSl9uG4-8Xg8jJSbXFVl5gXOUQj9RKI88aYRsvSSghPArjj0ie-LXW3N_pDg9qduUywDRSaNn1z_WK3Jncjib6un-_OA52eL1_hDMT7bJYLm4yF6Az7c0L9uNRsm3m97b_wDiumPD
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MHC+associations+of+ankylosing+spondylitis+in+East+Asians+are+complex+and+involve+non-HLA-B27+HLA+contributions&rft.jtitle=Arthritis+research+%26+therapy&rft.au=Wang%2C+Geng&rft.au=Kim%2C+Tae-Hwan&rft.au=Li%2C+Zhixiu&rft.au=Cortes%2C+Adrian&rft.date=2020-04-09&rft.issn=1478-6362&rft.eissn=1478-6362&rft.volume=22&rft.issue=1&rft.spage=74&rft_id=info:doi/10.1186%2Fs13075-020-02148-5&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-6362&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-6362&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-6362&client=summon